Cargando…
Current Trends in Neoantigen-Based Cancer Vaccines
Cancer immunotherapies are treatments that use drugs or cells to activate patients’ own immune systems against cancer cells. Among them, cancer vaccines have recently been rapidly developed. Based on tumor-specific antigens referred to as neoantigens, these vaccines can be in various forms such as m...
Autores principales: | Ho, Szu-Ying, Chang, Che-Mai, Liao, Hsin-Ni, Chou, Wan-Hsuan, Guo, Chin-Lin, Yen, Yun, Nakamura, Yusuke, Chang, Wei-Chiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056833/ https://www.ncbi.nlm.nih.gov/pubmed/36986491 http://dx.doi.org/10.3390/ph16030392 |
Ejemplares similares
-
Neoantigens elicit T cell responses in breast cancer
por: Morisaki, Takafumi, et al.
Publicado: (2021) -
Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018) -
Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019) -
Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022) -
The role of genetic polymorphisms in STIM1 and ORAI1 for erythropoietin resistance in patients with renal failure
por: Kao, Chih-Chin, et al.
Publicado: (2021)